Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2007
09/20/2007US20070220633 Comprises a cDNA sequence reverse transcribed from RNA of Cymbidium mosaic virus (CymMV); Virus induced gene silencing; viral vector whose transcripts induce gene inactivation in an orchid
09/20/2007US20070220632 Cotton Cultivar PM 3225 B2RF
09/20/2007US20070220631 Cotton Cultivar 06W650F
09/20/2007US20070220630 Cotton Cultivar DP 121 RF
09/20/2007US20070220629 transgenic plant having increased resistance to a picolinate auxin herbicide; has inhibited expression of the wild-type AFB5 gene
09/20/2007US20070220626 Sequences comprise transcriptional initiation regions associated with seed formation and seed tissues; plant regulatory elements natively associated with the nucleotide sequences coding for maize ; regulation of gene expression in plants, improving seed traits in plants
09/20/2007US20070220625 Pea cultivar FP2282
09/20/2007US20070220624 Pea cultivar FP2280
09/20/2007US20070220623 Lettuce cultivar 50-0401001-B
09/20/2007US20070220622 Nucleic acid molecules and other molecules associated with the cytokinin pathway
09/20/2007US20070219366 Method and Assembly for Dna Isolation With Dry Reagents
09/20/2007US20070219362 siRNA targeting azurocidin 1 (Cartionic Antimicrobial protein 37)
09/20/2007US20070219359 Gene Encoding Phosphoenolpyruvate Synthase In Plant Protection
09/20/2007US20070219347 Meningitidis B serogroup; amino acid sequence encoded by nucleotides 564043 to 565882 of sequence 1; monoclonal antibodies; vaccine antigens
09/20/2007US20070219152 Inhibition of Syk kinase expression
09/20/2007US20070219151 Methods and compositions for inhibiting the function of polynucleotide sequences
09/20/2007US20070219150 Nerve Cell Differentiation Inducer
09/20/2007US20070219148 Small Interfering RNA Specific to Sub-Units $g(a),$g(a)' and $g(b) of the Kinase Protein ck2,and the Applications of the Same
09/20/2007US20070219147 Insect Chymotrypsin and Inhibitors Thereof
09/20/2007US20070219122 Modified triple-helix forming oligonucleotides for targeted mutagenesis
09/20/2007US20070219116 Follicle Stimulating Hormone Superagonists
09/20/2007US20070218610 Methods of making a molecular detection chip having a metal oxide silicon field effect transistor on sidewalls of a micro-fluid channel
09/20/2007US20070218565 using a human Fc epsilon receptor (Fc68 R) to detect epsilon immunoglobulin (IgE); detecting a plant allergy in a canid, felid or equid
09/20/2007US20070218551 Novel Sirna-Based Approach to Target the Hif-Alpha Factor for Gene Therapy
09/20/2007US20070218550 Novel human LXRalpha variants
09/20/2007US20070218549 Compositions comprising conditioned cell culture media and uses thereof
09/20/2007US20070218547 Self assembling proteins for producing extended materials
09/20/2007US20070218536 Polyvalent Viral Vectors and a System for Production Thereof
09/20/2007US20070218533 Enhanced Alcohol Tolerant Microorganism and Methods of Use Thereof
09/20/2007US20070218532 Novel Escherichia coli having accession no. PTA 1579 and its use to produce polyhydroxybutyrate
09/20/2007US20070218529 Non-reducing saccharide-forming enzyme, trehalose-releasing enzyme, and process for producing saccharides using the enzymes
09/20/2007US20070218527 Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis
09/20/2007US20070218526 Method for zymotic production of fine chemicals containing sulphur (metA)
09/20/2007US20070218525 Process for Producing Dipeptides
09/20/2007US20070218524 Polypeptide Having Rnase III Activity
09/20/2007US20070218523 Modified human thymic stromal lymphopoietin
09/20/2007US20070218511 Methods for the diagnosis and treatment of lung cancer
09/20/2007US20070218507 Inhibitor of apoptosis proteins and nucleic acids and methods for making and using them
09/20/2007US20070218502 Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation
09/20/2007US20070218481 Method for identifying drug-sensitizing antisense DNA fragments and use thereof
09/20/2007US20070218477 Circular probe amplification (cpa) using energy-transfer primers
09/20/2007US20070218470 Method for selective inactivation of viral replication
09/20/2007US20070218463 Rearranged squamous cell carcinoma antigen genes II
09/20/2007US20070218461 Indole-Diterpene Biosynthesis
09/20/2007US20070218456 Cellular assays for signaling receptors
09/20/2007US20070218122 siRNA silencing of influenza virus gene expression
09/20/2007US20070218079 Method to induce rnai in prokaryotic organisms
09/20/2007US20070218078 Synergistic Attenuation of Vesicular Stomatitis Virus, Vectors Thereof and Immunogenic Compositions Thereof
09/20/2007US20070218077 Lipid-Mediated Polynucleotide Administration to Deliver a Biologically Active Peptide and to Induce a Cellular Immune Response
09/20/2007US20070218075 immunogens; glutamine based point mutations
09/20/2007US20070218073 Antigenic composition
09/20/2007US20070218071 Novel therapeutic targets in cancer
09/20/2007US20070218067 useful for monitoring the (de)activation status if the patient is treated with thrombocyte aggregation inhibitors
09/20/2007US20070218066 For clinical screening, diagnosis, prognosis, therapy and prophylaxis of conditions involving the pathology of epithelial cells and particularly those of the alimentary canal
09/20/2007US20070218051 Epitope peptides immunogenic against Streptococcus pneumoniae
09/20/2007US20070218048 Sfec, a Sperm Flagellar Energy Carrier Protein
09/20/2007US20070218044 Decomposition and modification of silicate and silicone by silicase and use of the reversible enzyme
09/20/2007US20070218031 Candidate drug which inhibits the interaction between AICD and p53 in neurons is selected as a drug for the prevention and/or treatment of Alzheimer's disease; provides treatment of Alzheimer's disease based on a different Alzheimer's disease onset mechanism from the amyloid hypothesis
09/20/2007US20070218026 DNA encoding the human serine protease EOS
09/20/2007US20070218003 Truncated Dance, Dance Complex And Method Of Using These
09/20/2007US20070218001 Biotherapeutics, Diagnostics and Research Reagents
09/20/2007US20070217999 Excretable Reporter Systems
09/20/2007DE19882435B4 Verfahren zur Hemmung von Krebszellwachstum mit einem pRb2/p130 exprimierenden Vektor Methods of inhibiting cancer cell growth with a pRb2 / p130 expressing vector
09/20/2007CA2649261A1 Influenza infection-inhibiting peptide, influenza virus-infection inhibitor, liposome and influenza preventive/therapeutic agent
09/20/2007CA2647935A1 Nucleic acid interaction analysis
09/20/2007CA2647280A1 Propagation of primary cells
09/20/2007CA2647221A1 A novel beta-galactoside-alpha2,6-sialyltransferase, a gene encoding thereof, and a method for producing thereof
09/20/2007CA2646317A1 Polyunsaturated fatty acid production in heterologous organisms using pufa polyketide synthase systems
09/20/2007CA2645740A1 Multivalent clostridial toxins
09/20/2007CA2645663A1 Detection of molecular interactions using a reduced affinity enzyme complementation reporter system
09/20/2007CA2645148A1 Soybean seed and oil compositions and methods of making same
09/20/2007CA2643078A1 Method and apparatus for avalanche-mediated transfer of agents into cells
09/20/2007CA2638975A1 Recombinant newcastle disease virus expressing h5 hemagglutinin of avian influenza virus
09/20/2007CA2638746A1 Recombinant mononegaviral virus vectors
09/20/2007CA2607677A1 Catalase gene and use thereof
09/19/2007EP1835038A1 Nucleic acid interaction analysis
09/19/2007EP1835035A1 A process for immobilizing cells on a resin
09/19/2007EP1835032A1 A self-inactivating recombinant lentiviral vector for the inhibition of HIV replication
09/19/2007EP1835031A1 Use of a recombinant modified vaccinia virus Ankara (MVA) for the treatment of type I hypersensitivity in a living animal including humans
09/19/2007EP1835030A1 OB fusion protein compositions and methods
09/19/2007EP1835029A1 Papillomavirus vaccines
09/19/2007EP1835028A1 The transcription factor gene osnacx from rice and use for improving tolerance of plants to drought and salt thereof
09/19/2007EP1835027A1 Novel cancer antigen peptide and the use thereof
09/19/2007EP1835026A1 Primer having promoter region added thereto
09/19/2007EP1835019A1 Hybridization apparatus and hybridization method
09/19/2007EP1834960A2 Immunomodulatory protein derived from the yaba monkey tumor virus
09/19/2007EP1834671A2 A method for generation of antibodies to cell surface molecules
09/19/2007EP1833991A2 Trefoil factors and methods of treating proliferation disorders using same
09/19/2007EP1833986A1 Determinants of sensitivity to chemotherapeutic agents
09/19/2007EP1833976A2 Methods and materials for expression of a recombinant protein
09/19/2007EP1833975A2 Regulated expression of transgenes in the central nervous system of mammals
09/19/2007EP1833974A2 Functional viral vectors for the overexpression or extinction of particular genes in plants, and applications thereof
09/19/2007EP1833973A2 A root-preferred, wound- and insect-inducible 2-oxoglutarate-dependent oxygenase promoter from maize and its use
09/19/2007EP1833972A2 Plants having increased yield and method for making the same
09/19/2007EP1833971A1 Plants having increased yield and method for making the same
09/19/2007EP1833970A2 Methods for producing soluble multi-membrane-spanning proteins
09/19/2007EP1833969A2 Polypeptides having nucleic acid binding activity
09/19/2007EP1833968A1 Cancer specific antibody and cell surface proteins
09/19/2007EP1833967A2 Conserved hbv and hcv sequences useful for gene silencing
09/19/2007EP1833966A2 Dnazymes for inhibition of japanese encephalitis virus replication